Parkinson’s Disease Professional Education Programs
APDA provides sponsorship support for select medical professional education opportunities to foster and encourage the sharing of ideas, knowledge, and possibilities among PD professionals.
Upcoming programs supported by APDA:
AI for Parkinson’s: From Data to Care in an Aging World
Artificial intelligence (AI) is rapidly reshaping healthcare, with growing implications for Parkinson’s disease research, diagnosis, treatment, and care. This conference will convene leaders across science, medicine, engineering, industry, and policy, informed by the unique expertise of the Parkinson’s community. Participants will explore how AI is currently being applied in the field and where it may have the greatest impact in the future
Thursday, November 19, 2026 (9AM – 5PM)
Johns Hopkins University Bloomberg Center
555 Pennsylvania Avenue NW
Washington, DC 20001
Sessions will address topics including:
- AI for biomarker discovery, diagnosis, and screening
- AI for treatment discovery and therapeutic innovation
- AI-enabled clinical care and patient support tools
- Ethics, privacy, and governance
- Perspectives from people with Parkinson’s disease and care partners
- Emerging technologies and startup innovation
The meeting is designed to foster cross-disciplinary discussion, encourage collaboration, and help shape future directions for AI in Parkinson’s disease.
APDA also proudly supported these recent programs:
Planning for Prevention of Parkinson’s & Related Synucleinopathies: A Trial Design Forum: Phoenix, AZ, May 22-24, 2026
Parkinson Study Group 33rd Annual Meeting Nashville, TN, Dec 5-8, 2024
Planning for Prevention of Parkinson’s: A Trial Design Forum (3rd in the series) Boston, MA, May 5-7, 2024
MDS-PAS Neuroscience of Parkinson’s Disease and Movement Disorders San Diego, CA, Nov 11, 2022
Planning for Prevention of Parkinson’s: A Trial Design Forum (2nd in the series) Boston, MA, and virtual Oct 2-3, 2022